Form 4 for OCUL OCULAR THERAPEUTIX, INC

Accepted 2026-01-26 00:00:00 ET · period of report 2026-01-21 · accession 0001104659-26-006711 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2026-01-26	2026-01-21	OCUL	Robinson David Wayne	Gbl CCO	A - Grant	$0.00	+136.0K	136.0K	New	$0
D	2026-01-26	2026-01-21	OCUL	Robinson David Wayne	Gbl CCO	A - Grant	$0.00	+416.0K	416.0K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-01-21	A	A	136,000	$0.00	136,000	D	—	—	(F1) On January 21, 2026, the reporting person was granted restricted stock units ("RSUs") under the 2019 Inducement Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Corporation"). Each RSU represents a right to receive one share of the Corporation's common stock. Subject to the reporting person's continued service to the Corporation, the RSUs will vest over three years, with 1/3 of the shares underlying the RSUs vesting on the one-year anniversary of the date of grant and an additional 1/3 of the shares underlying the RSUs vesting at the end of each successive one-year period thereafter.
2	Derivative	Stock Option (Right to Buy)	2026-01-21	A	A	416,000	$0.00	416,000	D	$11.42 · — to 2036-01-20	416,000 Common Stock	(F2) This option was granted on January 21, 2026 and vests over four years, with 25% of the shares underlying the option vesting on the one-year anniversary of the reporting person's first date of employment and the remainder vesting in equal monthly installments over the three years after such date.